Julie O'Neill

2018

In 2018, Julie O'Neill earned a total compensation of $7.7M as Former Executive Vice President of Global Operations at Alexion Pharmaceuticals, a 66% increase compared to previous year.

Compensation breakdown

Option Awards$170,607
Salary$486,053
Stock Awards$4,958,103
Other$2,088,571
Total$7,703,334

O'Neill received $5M in stock awards, accounting for 64% of the total pay in 2018.

O'Neill also received $170.6K in option awards, $486.1K in salary and $2.1M in other compensation.

Rankings

In 2018, Julie O'Neill's compensation ranked 1,076th out of 14,244 executives tracked by ExecPay. In other words, O'Neill earned more than 92.4% of executives.

ClassificationRankingPercentile
All
1,076
out of 14,244
92nd
Division
Manufacturing
361
out of 5,765
94th
Major group
Chemicals And Allied Products
112
out of 2,128
95th
Industry group
Drugs
86
out of 1,817
95th
Industry
Pharmaceutical Preparations
60
out of 1,391
96th
Source: SEC filing on March 26, 2019.

O'Neill's colleagues

We found five more compensation records of executives who worked with Julie O'Neill at Alexion Pharmaceuticals in 2018.

2018

Ludwig Hantson

Alexion Pharmaceuticals

Chief Executive Officer

2018

Paul Clancy

Alexion Pharmaceuticals

Chief Financial Officer

2018

Anne-Marie Law

Alexion Pharmaceuticals

Executive Vice President, Chief Patient and Employee Experience Officer

2018

Brian Goff

Alexion Pharmaceuticals

Executive Vice President and Chief Commercial Officer

2018

John Orloff

Alexion Pharmaceuticals

Executive Vice President, Head of Research & Development

News

You may also like